UFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
Follow UFPT
UFP Technologies, Inc. (UFPT) P/E ratio
As of 16 October 2026, UFP Technologies, Inc. (UFPT) trades at a P/E ratio of 31.2×. Over the past ten years it has ranged from 11.7× (March 2020) to 55.3× (September 2024); the current reading is higher than 83% of that period. That is above the Medical Devices industry median of 23.2× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 25.0× | (21.27%) |
| FY2024 | 31.8× | 12.92% |
| FY2023 | 28.2× | 34.48% |
| FY2022 | 20.9× | (37.12%) |
| FY2021 | 33.3× | 27.91% |
| FY2020 | 26.0× | 39.59% |
| FY2019 | 18.7× | 20.45% |
| FY2018 | 15.5× | (29.18%) |
| FY2017 | 21.9× | (5.75%) |
| FY2016 | 23.2× | 4.21% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 28.3× | 30.22% |
| Mar 2026 | 21.8× | (13.10%) |
| Dec 2025 | 25.0× | 9.36% |
| Sep 2025 | 22.9× | (18.16%) |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BFLY Butterfly Network, Inc. compare | n/m |
| ESTA Establishment Labs Holdings Inc. compare | n/m |
| NEOG Neogen Corporation compare | n/m |
| NVCR NovoCure Limited compare | n/m |
| AXGN AxoGen, Inc. compare | n/m |
| ATEC Alphatec Holdings, Inc. compare | n/m |
| INSP Inspire Medical Systems, Inc. compare | 14.8× |
| TMDX TransMedics Group, Inc. compare | 16.0× |
| UFPT UFP Technologies, Inc. | 31.2× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)